82 related articles for article (PubMed ID: 2274920)
1. The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins.
Hardisty RM; Powling MJ; Nokes TJ
Thromb Haemost; 1990 Aug; 64(1):150-5. PubMed ID: 2274920
[TBL] [Abstract][Full Text] [Related]
2. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
3. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
Lanza F; Stierlé A; Gachet C; Cazenave JP
Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
[TBL] [Abstract][Full Text] [Related]
5. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
6. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
7. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ influx and platelet membrane glycoproteins.
Yamaguchi A; Tanoue K; Yamazaki H
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1480-8. PubMed ID: 2629467
[TBL] [Abstract][Full Text] [Related]
9. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
[TBL] [Abstract][Full Text] [Related]
10. Penicillin-induced dysfunction of platelet membrane glycoproteins.
Pastakia KB; Terle D; Prodouz KN
J Lab Clin Med; 1993 Apr; 121(4):546-54. PubMed ID: 8454936
[TBL] [Abstract][Full Text] [Related]
11. Asialo von Willebrand factor binding to and aggregation of platelets: effects of inhibitors of platelet metabolism and function.
Williams SB; McKeown LP; Gralnick HR
J Lab Clin Med; 1987 May; 109(5):560-5. PubMed ID: 2437231
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ influx mediated through the GPIIb/IIIa complex during platelet activation.
Yamaguchi A; Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H
FEBS Lett; 1987 Dec; 225(1-2):228-32. PubMed ID: 3121391
[TBL] [Abstract][Full Text] [Related]
13. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
Brass LF; Shattil SJ
J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
15. Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene.
Apitz-Castro R; Jain MK; Bartoli F; Ledezma E; Ruiz MC; Salas R
Biochim Biophys Acta; 1991 Sep; 1094(3):269-80. PubMed ID: 1911878
[TBL] [Abstract][Full Text] [Related]
16. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
17. Differences between platelet and microparticle glycoprotein IIb/IIIa.
Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
[TBL] [Abstract][Full Text] [Related]
18. Effect of ticlopidine ex vivo on platelet intracellular calcium mobilization.
Derian CK; Friedman PA
Thromb Res; 1988 Apr; 50(1):65-76. PubMed ID: 3400086
[TBL] [Abstract][Full Text] [Related]
19. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
20. Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonist.
Freed MI; Boike S; Zariffa N; Jorkasky DK
Thromb Haemost; 1994 Oct; 72(4):622-6. PubMed ID: 7878642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
